BioSpace News Archive

Genetown

SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford

SpyBiotech, a biotechnology company with novel vaccine platform technologies that can target infectious diseases, cancer, and chronic diseases, announced a sponsored research agreement with The University of Oxford for the development of a vaccine against Epstein-Barr virus.

May 23, 2024
·
4 min read
Business

SystImmune, Inc. Announces Transition of Chief Medical Officer

SystImmune, Inc., a pioneering clinical-stage biopharmaceutical company focused on developing novel therapeutic bi-specific, multi-specific antibodies, and antibody-drug conjugates for the treatment of cancer, announced the appointment of Dr. Jonathan Cheng as Chief Medical Officer.

May 23, 2024
·
2 min read
Genetown

Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes

Haemonetics Corporation announced the pricing of its offering of $600,000,000 aggregate principal amount of 2.50% Convertible Senior Notes due 2029 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

May 23, 2024
·
11 min read
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium

Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium First presentation of a novel mechanism of action for the degradation of BRD9 – completely differentiated from cereblon- or VHL-based PROTACs.

May 23, 2024
·
4 min read
Lone Star Bio

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing

TFF Pharmaceuticals, Inc. today announced that the government will be advancing several next-generation medical countermeasures (MCMs) formulated with its Thin Film Freezing technology into advanced preclinical testing.

May 23, 2024
·
5 min read
BioMidwest

OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform

OneMedNet Corporation, the leading curator of regulatory-grade Real World Data, inclusive of electronic health records, laboratory results and medical imaging, is pleased to announce a greater than five -fold expansion of its proprietary iRWD™ network and platform.

May 23, 2024
·
4 min read
Business

ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q1 FINANCIAL RESULTS

ARCpoint Inc. announces that it will host a conference call at 11am Eastern time, Friday, May 24, 2024 to review the Company’s Q1 financial results for the period ending March 31, 2024.

May 23, 2024
·
12 min read
Biotech Bay

New Veeva Pulse Findings Show Connected Engagement Creates an Advantage as HCP Access Drops

Veeva Systems (NYSE: VEEV) today unveiled the latest findings from its Veeva Pulse Field Trends Report.

May 23, 2024
·
4 min read
CatalYm to Present Positive New Phase 2a Follow-up Data on GDF-15 Neutralizing Antibody Visugromab in Advanced NSCLC, Urothelial, and Hepatocellular Cancer at the 2024 ASCO Annual Meeting

CatalYm today announced that positive new follow-up results from its ongoing “GDFATHER” Phase 1/2a trial will be featured in an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024 in Chicago.

May 23, 2024
·
3 min read
Deals

Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing

Bicycle Therapeutics plc today announced that the company has entered into a securities purchase agreement with certain existing and new accredited investors to issue and sell an aggregate of 25,933,706 American Depositary Shares.

May 23, 2024
·
6 min read